ASX - By Stock
|
NEU |
Re:
Ann: Neuren receives Rare Pediatric Disease Designation from FDA
|
|
Innameonly
|
32 |
16K |
11 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
32
|
16K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
6 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
12K
|
5.9M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Angelman trial
|
|
Innameonly
|
71 |
41K |
1 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
71
|
41K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Possibly a new direction?
|
|
Innameonly
|
35 |
15K |
28 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
35
|
15K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Innameonly
|
906 |
437K |
17 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
906
|
437K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Innameonly
|
906 |
437K |
37 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
906
|
437K
|
37
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
24 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
12K
|
5.9M
|
24
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Innameonly
|
11K |
4.2M |
4 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
11K
|
4.2M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Innameonly
|
11K |
4.2M |
1 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
11K
|
4.2M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
82 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
12K
|
5.9M
|
82
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Innameonly
|
27K |
13M |
5 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
27K
|
13M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Innameonly
|
15K |
7.6M |
9 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
15K
|
7.6M
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
Innameonly
|
52 |
36K |
22 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
52
|
36K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
Innameonly
|
131 |
62K |
29 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
131
|
62K
|
29
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
5 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
12K
|
5.9M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Innameonly
|
554 |
207K |
11 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
554
|
207K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Innameonly
|
554 |
207K |
6 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
554
|
207K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Innameonly
|
11K |
4.2M |
2 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
11K
|
4.2M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Innameonly
|
11K |
4.2M |
12 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
11K
|
4.2M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Innameonly
|
1.3K |
753K |
6 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.3K
|
753K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
Innameonly
|
282 |
108K |
13 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
282
|
108K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
23 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
12K
|
5.9M
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
34 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
12K
|
5.9M
|
34
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Innameonly
|
906 |
437K |
9 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
906
|
437K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Innameonly
|
906 |
437K |
4 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
906
|
437K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
6 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
12K
|
5.9M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
17 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
12K
|
5.9M
|
17
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Pause in Trading
|
|
Innameonly
|
41 |
8.8K |
4 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
41
|
8.8K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
Innameonly
|
160 |
87K |
25 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
160
|
87K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
Innameonly
|
76 |
36K |
28 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
76
|
36K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
Innameonly
|
76 |
36K |
21 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
76
|
36K
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
Innameonly
|
160 |
87K |
69 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
87K
|
69
|
|
ASX - By Stock
|
NEU |
Re:
The Field of Play for NEU through the eyes of Ken (AKA The Professor)
|
|
Innameonly
|
29 |
17K |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
29
|
17K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
The Field of Play for NEU through the eyes of Ken (AKA The Professor)
|
|
Innameonly
|
29 |
17K |
7 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
29
|
17K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Innameonly
|
231 |
128K |
13 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
231
|
128K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
48 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
12K
|
5.9M
|
48
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
Innameonly
|
255 |
107K |
13 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
255
|
107K
|
13
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
Innameonly
|
255 |
107K |
9 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
255
|
107K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Innameonly
|
906 |
437K |
0 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
906
|
437K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
14 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
12K
|
5.9M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Innameonly
|
906 |
437K |
3 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
906
|
437K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
From the Professor...
|
|
Innameonly
|
178 |
88K |
11 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
178
|
88K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
12 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
12K
|
5.9M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Innameonly
|
12K |
5.9M |
12 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
12K
|
5.9M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Innameonly
|
194 |
83K |
10 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
194
|
83K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Innameonly
|
194 |
83K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
194
|
83K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Innameonly
|
194 |
83K |
34 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
194
|
83K
|
34
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Innameonly
|
194 |
83K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
194
|
83K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
TROFINETIDE PRIORITY REVIEW IN CANADA
|
|
Innameonly
|
3 |
2.4K |
17 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
3
|
2.4K
|
17
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Innameonly
|
11K |
4.2M |
24 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
11K
|
4.2M
|
24
|
|